We did a multicentre , randomised , double-blind , phase @ trial in which men with at least one bone metastasis from castration-resistant prostate cancer that had progressed after docetaxel treatment were randomly assigned in a @:@ ratio to receive bone-directed radiotherapy ( @ Gy in one fraction ) followed by either ipilimumab @ mg/kg or placebo every @ weeks for up to four doses .